** Hidden Jewel ** Undervalued Stock (Only Covid 19 vaccine alone, excluding gold and property biz, very prudent calculation)
10 million doses per annum for a 5-year period. In the event of unsold doses, the surplus shall be allowed to be sold with permission in other ASEAN and Indian subcontinent countries.
1) Assuming 10% commission = 10,000,000 doses X 5 years X RM 200 per dose X 10% Commission = RM 1bil net commission for 5 years, RM 200mil per year
2) Assuming 15% commission = 10,000,000 doses X 5 years X RM 200 per dose X 15% Commission = RM 1.5bil net commission for 5 years, RM 300mil per year
3) Assuming 20% commission = 10,000,000 doses X 5 years X RM 200 per dose X 20% Commission = RM 2bil net commission for 5 years, RM 400mil per year
Latest 4Q Revenue = RM 577,000 + 43,454,000 + 4,898,000 + 34,592,000 = RM 83.521mil Worst case scenario 10% = (200mil/83.521mil) 2.4X ; current SP 0.265 ; TP 0.635 in one year Mid case scenario 15% = (300mil/83.521mil) 3.6X ; current SP 0.265 ; TP 0.955 in one year Best case scenario 20% = (400mil/83.521mil) 4.8X ; current SP 0.265 ; TP 1.27 in one year
In my opinion, the reason why no operator in this stock is because this company has a very huge prospects. Only vaccine alone the TP can go up from 0.635 to 1.27. All Sifus here can please correct me if my calculation is wrong, please ignore all the grammar error, i only good at figures.
Stock: [YONGTAI]: YONG TAI BHD
2021-06-04 00:34 | Report Abuse
** Hidden Jewel **
Undervalued Stock (Only Covid 19 vaccine alone, excluding gold and property biz, very prudent calculation)
10 million doses per annum for a 5-year period. In the event of unsold doses, the surplus shall be allowed to be sold with permission in other ASEAN and Indian
subcontinent countries.
1) Assuming 10% commission
= 10,000,000 doses X 5 years X RM 200 per dose X 10% Commission = RM 1bil net commission for 5 years, RM 200mil per year
2) Assuming 15% commission
= 10,000,000 doses X 5 years X RM 200 per dose X 15% Commission = RM 1.5bil net commission for 5 years, RM 300mil per year
3) Assuming 20% commission
= 10,000,000 doses X 5 years X RM 200 per dose X 20% Commission = RM 2bil net commission for 5 years, RM 400mil per year
Latest 4Q Revenue = RM 577,000 + 43,454,000 + 4,898,000 + 34,592,000 = RM 83.521mil
Worst case scenario 10% = (200mil/83.521mil) 2.4X ; current SP 0.265 ; TP 0.635 in one year
Mid case scenario 15% = (300mil/83.521mil) 3.6X ; current SP 0.265 ; TP 0.955 in one year
Best case scenario 20% = (400mil/83.521mil) 4.8X ; current SP 0.265 ; TP 1.27 in one year
In my opinion, the reason why no operator in this stock is because this company has a very huge prospects. Only vaccine alone the TP can go up from 0.635 to 1.27.
All Sifus here can please correct me if my calculation is wrong, please ignore all the grammar error, i only good at figures.